Hepatitis-associated antigen in chronic liver disease

Measurement of the relative prompt production rate of χc2 and χc1 in pp collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015

Measurement of the top-quark mass in all-jets [Formula: see text] events in pp collisions at [Formula: see text] TeV.

The European physical journal. C, Particles and fields·2015

Search for supersymmetry in hadronic final states with missing transverse energy using the variables αT and b-quark multiplicity in pp collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015

Measurement of the sum of WW and WZ production with W+dijet events in pp collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015

Measurement of masses in the [Formula: see text] system by kinematic endpoints in pp collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015

Jet and underlying event properties as a function of charged-particle multiplicity in proton-proton collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Lancet (London, England)·2026

[Prevalencia de hepatitis B, hepatitis C y HTLV-1 mediante el uso del panel ampliado en mujeres embarazadas de dos ciudades de Colombia, 2024-2025].

Revista colombiana de obstetricia y ginecologia·2026

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre.

The Medical journal of Malaysia·2026

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.

Journal of the American College of Cardiology·2026

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults.

Journal of the American College of Cardiology·2026

Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.

Journal of viral hepatitis·2026

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

European heart journal·2026

Related Experiment Videos

Hepatitis-associated antigen in chronic liver disease

Related Concept Videos

Measurement of the relative prompt production rate of χc2 and χc1 in pp collisions at [Formula: see text].

Measurement of the top-quark mass in all-jets [Formula: see text] events in pp collisions at [Formula: see text] TeV.

Search for supersymmetry in hadronic final states with missing transverse energy using the variables αT and b-quark multiplicity in pp collisions at [Formula: see text].

Measurement of the sum of WW and WZ production with W+dijet events in pp collisions at [Formula: see text].

Measurement of masses in the [Formula: see text] system by kinematic endpoints in pp collisions at [Formula: see text].

Jet and underlying event properties as a function of charged-particle multiplicity in proton-proton collisions at [Formula: see text].

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial.

[Prevalencia de hepatitis B, hepatitis C y HTLV-1 mediante el uso del panel ampliado en mujeres embarazadas de dos ciudades de Colombia, 2024-2025].

Clinical characteristics and outcomes of myocardial infarction, stroke, and cardiovascular mortality among patients undergoing complex high-risk indicated percutaneous coronary intervention: A one-year review in a single non-surgical centre.

Intravenous Nicorandil in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary PCI: The CLEAN Randomized Clinical Trial.

Implications of the 2026 Versus 2018 ACC/AHA Multisociety Dyslipidemia Guidelines on the Clinical Care of U.S. Adults.

Attendance Among People With Hepatitis B in UK Secondary Care: A Scoping Review.

Gender-related risk of myocardial infarction and subclinical coronary atherosclerosis: a Danish population cohort study.

Related Experiment Videos

Hepatitis-associated antigen in chronic liver disease

Related Concept Videos

Related Articles